- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Addressing the Transition of Care For Patients with Schizophrenia: A Case Study Approach
Addressing the Transition of Care For Patients with Schizophrenia: A Case Study Approach
This is a Virtual Event for PsychU members in New York City, Upper/Lower Manhattan, and Rockland County, N.J.
In this presentation, the objectives are to:
- Review current challenges faced by patients with schizophrenia during the transition from hospital discharge to the community care setting
- Highlight published data on outcomes related to patient relapse, outpatient visit attendance, rehospitalization and the value of clinical bridging strategies
- Review interventions to assist in discharge planning
- Discuss antipsychotic medications and adherence issues
Featuring
-
Michael Townsend, MA, LCSW
Deputy Chief Executive Officer, Gateway Counseling Center
-
Jehan Marino, PharmD, BCPP (OPDC)
Clinical & Scientific Director
-
Becky Wong, PharmD, MBA (OPDC)
Clinical & Scientific Liaison
Speakers Jehan Marino, PharmD, BCPP and Becky Wong, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
February 14 3:00 pm to 4:00 pm
Register
This event registration is closed.
Stay Connected: